Literature DB >> 12671954

Quantitative rest activity in ambulatory monitoring as a physiological marker of restless legs syndrome: a controlled study.

Katinka Tuisku1, Matti Mikael Holi, Kristian Wahlbeck, Aulikki Johanna Ahlgren, Hannu Lauerma.   

Abstract

An objective marker of restless legs syndrome (RLS) is needed for developing diagnostic tools and monitoring symptoms. Actometric ambulatory monitoring of 15 RLS patients and 15 healthy controls was undertaken in order to differentiate between RLS-related motor symptoms and normal motor activity. Nocturnal lower-limb activity per minute differentiated and discriminated between groups with no overlap, whereas the periodic limb movement index and the controlled rest activity during sitting showed less discriminative power. The naturalistic recording of nocturnal activity by actometry may prove useful for assessing the severity of RLS and for finding an objective marker to support the diagnosis of RLS. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2003        PMID: 12671954     DOI: 10.1002/mds.10381

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  3 in total

1.  Children show individual night-to-night variability of periodic limb movements in sleep.

Authors:  Matthew A Picchietti; Daniel L Picchietti; Sandra J England; Arthur S Walters; Barbara V Couvadelli; Daniel S Lewin; Wayne Hening
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

2.  Quantitative evaluation of severity of behavioral and psychological symptoms of dementia in patients with vascular dementia.

Authors:  Wei-Dong Pan; Sohei Yoshida; Qian Liu; Chun-Lan Wu; Jun Wang; Jin Zhu; Ding-Fang Cai
Journal:  Transl Neurodegener       Date:  2013-04-22       Impact factor: 8.014

3.  Altered heart rate dynamics associated with antipsychotic-induced subjective restlessness in patients with schizophrenia.

Authors:  Jong-Hoon Kim; Jun-Hyung Ann; Jinyoung Lee; Mee-Hee Kim; Ah-Young Han
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-19       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.